 | Kezar Life Sciences, Inc. | |||
| NMS : KZR || Location: United States | ||||
$0.790.0 (0.32%) |
0.14 M | 0.78 - 0.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.567 M |
| March 15, 2024 | 3.380 M |
| Feb. 29, 2024 | 3.181 M |
| Feb. 15, 2024 | 3.002 M |
| Jan. 31, 2024 | 3.050 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.38 | -0.44 | -14.70% |
| 09/30/2023 | -0.35 | -0.32 | 9.27% |
| 06/30/2023 | -0.32 | -0.34 | -5.20% |
| 03/31/2023 | -0.29 | -0.31 | -6.46% |
| 12/31/2022 | -0.28 | -0.25 | 10.49% |
KZR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 72.801M | Shares Float | 52.499M |
| Short Float | 3.567M | Market Cap | 57.51M |
| Institution ownership | 67.93% | Insider ownership | 14.807% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.40 | Forward EPS | -1.25 |